Dr.Guttler’s Patient Thyroid Blog Post: Use of cold 5% Dextrose Water can treat the voice changes occurring during the RFA treatment. Call me for an evaluation for thyroid RFA. 3102928860 or email to thyroid.manager@thyroid.com. Ask for...
More infoDr.Guttler’s Patient Thyroid Blog Post on Radiofrequency ablation for small thyroid cancers
Dr.Guttler’s Patient Thyroid Blog Post on Radiofrequency ablation for small thyroid cancers Dr.Guttler’s comments: Thyroid RFA can ablate the cancer without surgery or life long follow up as in Active surveillance. Not all patients...
More infoDr.Guttler’s Patient Blog post: Thyroid RFA By JH Baek Classic Paper
Dr.Guttler’s Patient Blog post: Thyroid RFA By JH Baek Classic Paper. Dr.Guttler’s Comments: 1.This is a classic article on Thyroid RFA. 2. Read it and then call me for an evaluation. 3103938860 or thyroid.manager@thyroid.com Ask for...
More infoDr.Guttler’s Patient Thyroid Blog Posts: PET/CT can it Prevent futile surgery on indeterminate thyroid nodules? This paper suggests the answer is yes.
Dr.Guttler’s Patient Thyroid Blog Posts: PET/CT can it Prevent futile surgery on indeterminate thyroid nodules? This paper suggests the answer is yes. E. deKoster et al Eur J. Nucl Med Mol Imaging April 2022 49: 1970-84. Dr.Guttler’s...
More infoDr.Guttler’s Patient Thyroid Blog Post: Radiofrequency Ablation for Thyroid Papillary Microcarcinoma
Dr.Guttler’s Patient Thyroid Blog Post: Radiofrequency Ablation for Thyroid Papillary Microcarcinoma Dr.Guttler’s comments: 1. Dr Allen Ho came to my center to observe a patient of mine having thyroid RFA for a thyroid nodule. Now he...
More infoDr.Guttler’s Patient Thyroid Blog Post: Can PET/CT prevent surgery in Class III atypical thyroid nodules?
Dr.Guttler’s Patient Thyroid Blog Post: Can PET/CT prevent surgery in Class III atypical thyroid nodules? A.Piccardo et al Endocrine 2020 69-533-561 Dr.Guttler’s comments: 1. 111 patients were classified as Class III cytology. 67Class...
More infoDr.Guttler’s Thyroid Patient Blog Post: Enhanced Well Being in Some Patients on Excessive Thyroid Hormone Replacement or With Untreated Graves’ Disease
Dr.Guttler’s Thyroid Patient Blog Post: Enhanced Well Being in Some Patients on Excessive Thyroid Hormone Replacement or With Untreated Graves’ Disease P. Perros et al Int.J. Endocrinology May 2022 Dr.Guttler’s comments: 1...
More infoDr.Guttler’s Thyroid Patient Blog Post: When is Molecular Testing in Class III or IV nodules needed?
Dr.Guttler’s Thyroid Patient Blog Post: When is Molecular Testing in Class III or IV nodules needed? Almost always! DR.Guttler’s Comments: The study results were that Cytology and Ultrasound were not able alone or together able to...
More infoDr.Guttler’s website Thyroid.com is the first page of google sites for each of the main uses for radiofrequency and ethanol ablation.
Searches for “thyroidologist doing Radiofrequency ablation or ethanol ablation” for 1. benign thyroid nodules and thyroid and parathyroid cysts 2. micropapillary thyroid cancer. 3.recurrenct neck cancer lymph nodes. 4. Parathyroid...
More infoDiagnostic Parathyroid Ultrasound: Most successful imaging method in locating the Parathyroid adenoma in the neck.
Endocrine Practice 27 (2021) 1193-1198 Baser O.O. et al. DR.Guttler’s Comments: In 268/348 cases the US detected the location in 77% of the PTAs. Spect-CT 254/348 73% and parathyroid scan 209/348 60% Spect-CT was better at chest locations...
More infoDr.Guttler’s Patient Thyroid Blog Post: Hypothyroidism in the Elderly
Reference: Leonidas H. Duntas et al Endocrine volume 66, pages 63–69 (2019) Dr.Guttler’s comments: 1. The population is aging with millions of people today living into their 90 s. 2.Hypothyroidism, is widespread and it is expected to...
More infoDr.Guttler’s Patient Thyroid Blog Post: New Drug for Graves’ Thyroid Eye Disease TED
Dr.Guttler’s Patient Thyroid Blog Post: New Drug for Graves’ Thyroid Eye Disease TED Dr.Guttler’s comments: 1. An editorial on the new drug Teprotumumab for TED. 2. First Food and Drug Administration (FDA)-approved treatment for...
More info